1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4: Decision thresholds
Threshold Sensitivity Specificity
Max PSR % in lymphoma from other >94 100 69
>114 82 93
>136 72 100
Mean PSR % in lymphoma from other >70 100 34
>120 59 100
>103 78 94
Mean PSR % in metastases from other <40 .50 100
<75 100 83
<67 95 85
Min PSR % in metastases from other <40 .50 100
<72 100 81
<51 86 89

	Threshold	Sensitivity	Specificity
Max PSR % in lymphoma from other	>94	100	69
	>114	82	93
	>136	72	100
Mean PSR % in lymphoma from other	>70	100	34
	>120	59	100
	>103	78	94
Mean PSR % in metastases from other	<40	.50	100
	<75	100	83
	<67	95	85
Min PSR % in metastases from other	<40	.50	100
	<72	100	81
	<51	86	89